Heterogeneity in unclassifiable interstitial lung disease a systematic review and meta-analysis

Annals of the American Thoracic Society

Volumn 15, Issue 7, 2018, Pages 854-863

  Guler, Sabina A ^a,b   Ellison, Kina ^a   Algamdi, Mohmmed ^a,b,c   Collard, Harold R ^d   Ryerson, Christopher J ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c KING FAHAD MEDICAL CITY   (Saudi Arabia)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Classification; Diagnosis; Heterogeneity; Interstitial lung disease; Pulmonary fibrosis

Indexed keywords

CLINICAL FEATURE; CONSENSUS; GENETIC HETEROGENEITY; HUMAN; INTERSTITIAL LUNG DISEASE; LAVAGE; LUNG BIOPSY; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; REVIEW; RISK FACTOR; SELECTION BIAS; SURVIVAL; SYSTEMATIC REVIEW; VITAL CAPACITY; BIOPSY; DISEASE MANAGEMENT; GLOBAL HEALTH; LUNG; PATHOLOGY; PROGNOSIS;

BIOPSY; DISEASE MANAGEMENT; GLOBAL HEALTH; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; PREVALENCE; PROGNOSIS;

EID: 85049662866     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201801-067OC     Document Type: Review

References (91)

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
2. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al.; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-748.
3. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al.; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-2082.
4. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al.; ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2083-2092.
5. Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ; Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968-1977.
6. Walsh SLF, Wells AU, Desai SR, Poletti V, Piciucchi S, Dubini A, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med 2016;4:557-565.
7. Leung SC, Churg AM, Leipsic JA, Levy RD, Wilcox PG, Ryerson CJ. Unclassifiable interstitial lung disease: an unresolved diagnostic dilemma. Respirol Case Rep 2015;3:85-88.
8. Clarivate Analytics. EndNote X7. 2016 [accessed 2017 Nov 1]. Available from: www.endnote.com.
9. Vertitas Health Innovation. Covidence systematic review software. 2016 [accessed 2017 Nov 1]. Available from: www.covidence.org.
10. Jacob J, Bartholmai BJ, Rajagopalan S, Egashira R, Brun AL, Kokosi M, et al. Unclassifiable-interstitial lung disease: outcome prediction using CT and functional indices. Respir Med 2017;130:43-51.
11. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 2012;65:934-939.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
13. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health 2013;67:974-978.
14. Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH. Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw 2012;49:1-15.
15. R Development Core Team.R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2016.
16. Ahmad K, Barba T, Gamondes D, Ginoux M, Khouatra C, Spagnolo P, et al. Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med 2017;123:56-62.
17. Aihara K, Handa T, Nagai S, Tanizawa K, Ikezoe K, Watanabe K, et al. Impaired endothelium-dependent vasodilator response in patients with pulmonary fibrosis. Respir Med 2013;107:269-275.
18. Alsumrain M, De Giacomi F, Mirza S, Moua T. Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review. Respir Res 2017;18:161.
19. Andersen C, Mellemkjær S, Hilberg O, Bendstrup E. NT-proBNP,95 ng/l can exclude pulmonary hypertension on echocardiography at diagnostic workup in patients with interstitial lung disease. Eur Clin Respir J 2016;3:32027.
20. Bando M, Ohno S, Hosono T, Yanase K, Sato Y, Sohara Y, et al. Risk of acute exacerbation after video-assisted thoracoscopic lung biopsy for interstitial lung disease. J Bronchology Interv Pulmonol 2009;16: 229-235.
21. Bauer PR, Kalra S, Osborn TG, St Sauver J, Hanson AC, Schroeder DR, et al. Influence of autoimmune biomarkers on interstitial lung diseases: a tertiary referral center based case-control study. Respir Med 2015;109:397-405.
22. Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, et al. The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia. Thorax 2017;72: 424-429.
23. Cascante JA, Cebollero P, Herrero S, Yagüe A, Echegoyen A, Elizalde J, et al. Transbronchial cryobiopsy in interstitial lung disease: are we on the right path? J Bronchology Interv Pulmonol 2016;23:204-209.
24. Casoni GL, Tomassetti S, Cavazza A, Colby TV, Dubini A, Ryu JH, et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One 2014;9:e86716.
25. Chartrand S, Swigris JJ, Stanchev L, Lee JS, Brown KK, Fischer A. Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience. Respir Med 2016; 119:150-154.
26. Flaherty KR, Toews GB, Travis WD, Colby TV, Kazerooni EA, Gross BH, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002;19:275-283.
27. Guler SA, Berezowska SA, Christe A, Geiser T, Funke-Chambour M. Multidisciplinary discussion for diagnosis of interstitial lung disease in real life. Swiss Med Wkly 2016;146:w14318.
28. Hagmeyer L, Theegarten D, Wohlschläger J, Treml M, Matthes S, Priegnitz C, et al. The role of transbronchial cryobiopsy and surgical lung biopsy in the diagnostic algorithm of interstitial lung disease. Clin Respir J 2016;10:589-595.
29. Hashisako M, Karata H, Ishida K, Groen R, Tanaka T, Tabata K, et al. ORAL PRESENTATION, Web-based multidisciplinary discussion of unclassifiable interstitial pneumonia. Respirology 2016;21:20-79.
30. Holland AE, Fiore JF Jr, Bell EC, Goh N, Westall G, Symons K, et al. Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology 2014;19:1215-1221.
31. Huie TJ, Olson AL, Cosgrove GP, Janssen WJ, Lara AR, Lynch DA, et al. A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes. Respirology 2010;15: 909-917.
32. Hyldgaard C, Bendstrup E, Wells AU, Hilberg O. Unclassifiable interstitial lung diseases: clinical characteristics and survival. Respirology 2017;22:494-500.
33. Hyldgaard C, Hilberg O, Muller A, Bendstrup E. A cohort study of interstitial lung diseases in central Denmark. Respir Med 2014;108: 793-799.
34. Ikezoe K, Handa T, Tanizawa K, Chen-Yoshikawa TF, Kubo T, Aoyama A, et al. Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease. PLoS One 2017;12: e0183171.
35. Jo HE, Glaspole IN, Levin KC, McCormack SR, Mahar AM, Cooper WA, et al. Clinical impact of the interstitial lung disease multidisciplinary service. Respirology 2016;21:1438-1444.
36. Karakatsani A, Papakosta D, Rapti A, Antoniou KM, Dimadi M, Markopoulou A, et al.; Hellenic Interstitial Lung Diseases Group. Epidemiology of interstitial lung diseases in Greece. Respir Med 2009; 103:1122-1129.
37. Kato S, Sekine A, Kusakawa Y, Ogura T, Futaki M, Iwasawa T, et al. Prognostic value of cardiovascular magnetic resonance derived right ventricular function in patients with interstitial lung disease. J Cardiovasc Magn Reson 2015;17:10.
38. López-Campos JL, Rodríguez-Becerra E; Neumosur Task Group; Registry of Interstitial Lung Diseases. Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study. Eur J Epidemiol 2004;19:155-161.
39. Manfredi A, Sebastiani M, Cerri S, Della Casa G, Giuggioli D, Vacchi C, et al. Unclassifiable interstitial lung disease or undifferentiated connective tissue disease? A challenging differential diagnosis [abstract]. Ann Rheum Dis 2015;74:591.
40. Mikamo M, Fujisawa T, Oyama Y, Kono M, Enomoto N, Nakamura Y, et al. Clinical significance of forced oscillation technique for evaluation of small airway disease in interstitial lung diseases. Hai 2016;194: 975-983.
41. Milne KM, Kwan JM, Guler S, Winstone TA, Le A, Khalil N, et al. Frailty is common and strongly associated with dyspnoea severity in fibrotic interstitial lung disease. Respirology 2017;22:728-734.
42. Morell F, Reyes L, Doménech G, DeGracia J,Majó J, Ferrer J. Diagnoses and diagnostic procedures in 500 consecutive patients with clinical suspicion of interstitial lung disease [in Spanish]. Arch Bronconeumol 2008;44:185-191.
43. Narita J, Hasegawa T, Tsuchida M, Terada M, Takada T, Hashimoto T, et al. Analysis of the effect of surgical lung biopsy on serumKL-6 Levels in patients with interstitial pneumonia: surgical lung biopsy does not elevate serum KL-6 levels. Intern Med 2006;45:615-619.
44. Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L, et al. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 2016;47:1767-1775.
45. Patterson KC, Shah RJ, Porteous MK, Christie JD, D'Errico CA, Chadwick M, et al. Interstitial lung disease in the elderly. Chest 2017; 151:838-844.
46. Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J 2013;42:750-757.
47. Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, et al. Predicting survival across chronic interstitial lung disease: the ILDGAP model. Chest 2014;145:723-728.
48. Thomeer MJ, Vansteenkiste J, Verbeken EK, Demedts M. Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment. Respir Med 2004;98:567-573.
49. Tomassetti S, Cavazza A, Colby TV, Ryu JH, Nanni O, Scarpi E, et al. Transbronchial biopsy is useful in predicting UIP pattern. Respir Res 2012;13:96.
50. Tomassetti S, Wells AU, Costabel U, Cavazza A, Colby TV, Rossi G, et al. Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2016;193:745-752.
51. Triantafillidou C, Dimakou K, Thanos L, Toumbis M. Characteristics, management and outcome of hospitalized patients with interstitial lung disease in Greece. Pneumon 2015;28:154-160.
52. Vial-Dupuy A, Sanchez O, Douvry B, Guetta L, Juvin K, Wermert D, et al. Outcome of patients with interstitial lung disease admitted to the intensive care unit. Sarcoidosis Vasc Diffuse Lung Dis 2013;30:134-142.
53. Walterspacher S, Schlager D, Walker DJ, Müller-Quernheim J,Windisch W, Kabitz HJ. Respiratory muscle function in interstitial lung disease. Eur Respir J 2013;42:211-219.
54. Chaudhuri N, Spencer L, Greaves M, Bishop P, Chaturvedi A, Leonard C. A review of the multidisciplinary diagnosis of interstitial lung diseases: a retrospective analysis in a single UK specialist centre. J Clin Med 2016;5:E66.
55. George G, Rosas IO, Cui Y, McKane C, Hunninghake GM, Camp PC, et al. Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease. Chest 2015; 147:1549-1557.
56. Luo Q, Han Q, Chen X, Xie J, Wu L, Chen R. The diagnosis efficacy and safety of video-assisted thoracoscopy surgery (VATS) in undefined interstitial lung diseases: a retrospective study. J Thorac Dis 2013;5: 283-288.
57. Musellim B, Okumus G, Uzaslan E, Akgün M, Cetinkaya E, Turan O, et al.; Turkish Interstitial Lung Diseases Group. Epidemiology and distribution of interstitial lung diseases in Turkey. Clin Respir J 2014;8:55-62.
58. Sakamoto S, Homma S, Mun M, Fujii T, Kurosaki A, Yoshimura K. Acute exacerbation of idiopathic interstitial pneumonia following lung surgery in 3 of 68 consecutive patients: a retrospective study. Intern Med 2011;50:77-85.
59. Samejima J, Tajiri M, Ogura T, Baba T, Omori T, Tsuboi M, et al. Thoracoscopic lung biopsy in 285 patients with diffuse pulmonary disease. Asian Cardiovasc Thorac Ann 2015;23:191-197.
60. Shen N. The analysis of interstitial lung disease with pulmonary hypertension. Respirology 2011;16:324.
61. Tanriverdi H, Erboy F, Altinsoy B, Uygur F, Arasli M, Tekin IO, et al. Bronchoalveolar lavage fluid characteristics of patients with sarcoidosis and nonsarcoidosis interstitial lung diseases: ten-year experience of a single center in Turkey. Iran Red Crescent Med J 2015; 17:e31103.
62. Xaubet A, Ancochea J, Morell F, Rodriguez-Arias JM, Villena V, Blanquer R, et al.; Spanish Group on Interstitial Lung Diseases, SEPAR. Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis 2004;21:64-70.
63. Strâmbu I, Belaconi I, Stoicescu I, Ioniţǎ D, Cojocaru F, Niţǎ C, et al. Interstitial lung diseases: an observational study in patients admitted in "Marius Nasta" Institute of Pulmonology Bucharest, Romania, in 2011. Pneumologia 2013;62:206-211.
64. Siemienowicz ML, Kruger SJ, GohNS, Dobson JE, Spelman TD, FabinyRP. Agreement and mortality prediction in high-resolution CT of diffuse fibrotic lung disease. J Med Imaging Radiat Oncol 2015;59: 555-563.
65. Chen H, Fang X, Zhu H, Li S, He J, Gu P, et al. Gene expression profile analysis for different idiopathic interstitial pneumonias subtypes. Exp Lung Res 2014;40:367-379.
66. Brewis MJ, Church AC, Johnson MK, Peacock AJ. Severe pulmonary hypertension in lung disease: phenotypes and response to treatment. Eur Respir J 2015;46:1378-1389.
67. Khadawardi H, Mura M. A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease. Respirology 2017;22:501-507.
68. Singh S, Collins BF, Sharma BB, Joshi JM, Talwar D, Katiyar S, et al. Interstitial lung disease in India: results of a prospective registry. Am J Respir Crit Care Med 2017;195:801-813.
69. Ferri C, Manfredi A, Sebastiani M, Colaci M, Giuggioli D, Vacchi C, et al. Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatologypneumology experience, and review of the literature. Autoimmun Rev 2016;15:61-70.
70. Kondoh Y, Johkoh T, Fukuoka J, Tanaka T, Tabata K, Yamano Y, et al. Multidisciplinary evaluation of unclassifiable idiopathic interstitial pneumonias [abstract]. Am J Respir Crit Care Med 2014;189:A6399.
71. Drakopanagiotakis F, ElGuelai M, Bonniaud P, Vancheri C, Crestani B, Wagner J, et al. Clinical characteristics of patients with unclassifiable interstitial lung disease [abstract]. Presented at the European Respiratory Journal Conference: European Respiratory Society Annual Congress. September 26-30, 2015, Amsterdam, Netherlands. PA4860.
72. Skolnik K, Ryerson CJ. Unclassifiable interstitial lung disease: a review. Respirology 2016;21:51-56.
73. Cottin V, Wells A. Unclassified or unclassifiable interstitial lung disease: confusing or helpful disease category? Eur Respir J 2013;42:576-579.
74. Johannson KA, Marcoux VS, Ronksley PE, Ryerson CJ. Diagnostic yield and complications of transbronchial lung cryobiopsy for interstitial lung disease. a systematic review and metaanalysis. Ann Am Thorac Soc 2016;13:1828-1838.
75. DiBardino DM, Haas AR, Lanfranco AR, Litzky LA, Sterman D, Bessich JL. High complication rate after introduction of transbronchial cryobiopsy into clinical practice at an academic medical center. Ann Am Thorac Soc 2017;14:851-857.
76. Patel NM, Borczuk AC, Lederer DJ. Cryobiopsy in the diagnosis of interstitial lung disease. a step forward or back? Am J Respir Crit Care Med 2016;193:707-709.
77. Flaherty KR, King TE Jr, Raghu G, Lynch JP III, Colby TV, Travis WD, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004;170:904-910.
78. Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, et al.; IPF Project Consortium. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. Eur Respir J 2017;50:1700936.
79. Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, et al.; "ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD". An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015;46:976-987.
80. Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest 2011;140:1292-1299.
81. Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 2007;176:691-697.
82. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 2010;138:251-256.
83. Corte TJ, Copley SJ, Desai SR, Zappala CJ, Hansell DM, Nicholson AG, et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012;39:661-668.
84. Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SLF, Myers JL, et al. A standardized diagnostic ontology for fibrotic interstitial lung disease. an international working group perspective. Am J Respir Crit Care Med 2017;196:1249-1254.
85. Alhamad EH. Interstitial lung diseases in Saudi Arabia: a single-center study. Ann Thorac Med 2013;8:33-37.
86. Ford-Sahibzada CA, Johannson KA, Goobie GC, Fell CD. Clinical characterization of interstitial lung disease patients: report from a single center longitudinal database [abstract]. Am J Respir Crit Care Med 2017;195:A3473.
87. Kreuter M, Herth FJF, Wacker M, Hammerl P, Wiederhold C, Leidl R, et al. Interims analysis of the EXCITINGILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases) [abstract]. Presented at European Respiratory Journal Conference: European Respiratory Society Annual Congress September 3-7, 2016, London, United Kingdom. PA3905.
88. Low SY. Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease [abstract]. Presented at European Respiratory Journal Conference: European Respiratory Society Annual Congress September 3-7, 2016, London, United Kingdom. PA814.
89. Reineck LA, Sundaram B, Schmidt SL, Han MK, Schmidt LA, Myers JL, et al. Clinical and radiologic characterization of patients with nonclassifiable interstitial pneumonias [abstract]. Am J Respir Crit Care Med 2010;181:A1124.
90. Wang H, Luo Q, Han Q, Chen M, Kolb MRJ, Chen R. The etiology of idiopathic interstitial pneumonias (IIP) in Chinese patients: a single center serial cases analysis [abstract]. Am J Respir Crit Care Med 2015;191:A1576.
91. Tanizawa K, Handa T, Nagai S, Hirai T, Kubo T, Oguma T, et al. Clinical impact of high-attenuation and cystic areas on computed tomography in fibrotic idiopathic interstitial pneumonias. BMC Pulm Med 2015;15:74.